Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Subscribe To Our Newsletter & Stay Updated